GlassScriptPhysician profile
Yan Yang
NPI 1801249461
$2,835.41
in general payments reported to CMS, 2019-2025
11 companies · $751 in 2025
The $751 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $107 · 2023: $1,222 · 2024: $756 · 2025: $751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,533 · Travel and Lodging: $1,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,532.97 |
| Travel and Lodging | $1,195.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $927.41 | 2023 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Boston Scientific Corporation | $871.34 | 2024-2025 | General - Therapies, Intracept, Wavewriter Alpha Prime 16 |
| Saluda Medical Americas, INC. | $318.74 | 2021-2024 | Evoke |
| Spr Therapeutics, INC | $222.14 | 2023-2024 | Sprint Pns System |
| Nevro Corp. | $142.84 | 2023 | Senza |
| Novartis Pharmaceuticals Corporation | $122.07 | 2024 | |
| Amgen INC. | $121.83 | 2025 | Tavneos |
| Integra Lifesciences Corporation | $49.66 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Collegium Pharmaceutical, INC. | $24.23 | 2025 | Belbuca |
| Abbott Laboratories | $18.30 | 2024 | Eterna |
| Vertos Medical, INC. | $16.85 | 2023 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yan Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.